|
|
locomotion
|
GO:0040011 |
313 |
0.940
|
|
|
|
regulation of metabolic process
|
GO:0019222 |
359 |
0.716
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.709
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.681
|
|
|
|
nucleic acid templated transcription
|
GO:0097659 |
181 |
0.632
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.615
|
|
|
|
nucleobase containing compound metabolic process
|
GO:0006139 |
274 |
0.610
|
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.599
|
|
|
|
cell fate specification
|
GO:0001708 |
68 |
0.595
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.578
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.577
|
|
|
|
gene expression
|
GO:0010467 |
252 |
0.569
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.562
|
|
|
|
cellular macromolecule biosynthetic process
|
GO:0034645 |
224 |
0.551
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.455
|
|
|
|
regulation of primary metabolic process
|
GO:0080090 |
311 |
0.454
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.452
|
|
|
|
organic cyclic compound biosynthetic process
|
GO:1901362 |
223 |
0.448
|
|
|
|
heterocycle metabolic process
|
GO:0046483 |
290 |
0.441
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.439
|
|
|
|
regulation of macromolecule metabolic process
|
GO:0060255 |
317 |
0.423
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
143 |
0.408
|
|
|
|
neuron fate specification
|
GO:0048665 |
20 |
0.407
|
|
|
|
biosynthetic process
|
GO:0009058 |
294 |
0.399
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.398
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.378
|
|
|
|
positive regulation of macromolecule metabolic process
|
GO:0010604 |
93 |
0.378
|
|
|
|
macromolecule biosynthetic process
|
GO:0009059 |
227 |
0.365
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.341
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.331
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.328
|
|
|
|
neuron fate commitment
|
GO:0048663 |
26 |
0.322
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.314
|
|
|
|
central nervous system development
|
GO:0007417 |
387 |
0.300
|
|
|
|
glial cell migration
|
GO:0008347 |
3 |
0.282
|
|
|
|
regulation of transcription dna templated
|
GO:0006355 |
213 |
0.281
|
|
|
|
gliogenesis
|
GO:0042063 |
45 |
0.269
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.268
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.266
|
|
|
|
endocrine system development
|
GO:0035270 |
65 |
0.264
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
163 |
0.261
|
|
|
|
generation of neurons
|
GO:0048699 |
385 |
0.259
|
|
|
|
heart formation
|
GO:0060914 |
13 |
0.259
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.258
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
12 |
0.251
|
|
|
|
stem cell proliferation
|
GO:0072089 |
4 |
0.249
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.245
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.234
|
|
|
|
cardioblast migration
|
GO:0003260 |
7 |
0.233
|
|
|
|
eye morphogenesis
|
GO:0048592 |
144 |
0.232
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
47 |
0.231
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.228
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.228
|
|
|
|
regulation of cellular metabolic process
|
GO:0031323 |
320 |
0.223
|
|
|
|
response to chemical
|
GO:0042221 |
320 |
0.220
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.214
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.204
|
|
|
|
homeostatic process
|
GO:0042592 |
142 |
0.201
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
116 |
0.199
|
|
|
|
pharyngeal muscle development
|
GO:0043282 |
4 |
0.194
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.194
|
|
|
|
cell fate commitment
|
GO:0045165 |
99 |
0.194
|
|
|
|
response to organic substance
|
GO:0010033 |
153 |
0.194
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.192
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.192
|
|
|
|
transport
|
GO:0006810 |
220 |
0.192
|
|
|
|
brain development
|
GO:0007420 |
293 |
0.188
|
|
|
|
transcription dna templated
|
GO:0006351 |
181 |
0.187
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.186
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
3 |
0.182
|
|
|
|
cell migration to the midline involved in heart development
|
GO:0003318 |
12 |
0.182
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.181
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.177
|
|
|
|
neuron differentiation
|
GO:0030182 |
353 |
0.176
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.176
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
18 |
0.174
|
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.174
|
|
|
|
dorsal ventral axis specification
|
GO:0009950 |
14 |
0.170
|
|
|
|
lateral line system development
|
GO:0048925 |
76 |
0.168
|
|
|
|
establishment of localization
|
GO:0051234 |
244 |
0.167
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.167
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.162
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.161
|
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.159
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.159
|
|
|
|
regulation of nucleic acid templated transcription
|
GO:1903506 |
213 |
0.156
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.152
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
195 |
0.151
|
|
|
|
head development
|
GO:0060322 |
303 |
0.151
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
63 |
0.149
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.146
|
|
|
|
regulation of multicellular organismal process
|
GO:0051239 |
277 |
0.145
|
|
|
|
axon extension
|
GO:0048675 |
45 |
0.139
|
|
|
|
cell migration involved in heart development
|
GO:0060973 |
22 |
0.137
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
40 |
0.136
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.136
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.136
|
|
|
|
regulation of cellular biosynthetic process
|
GO:0031326 |
245 |
0.135
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
74 |
0.134
|
|
|
|
hindbrain development
|
GO:0030902 |
91 |
0.134
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.133
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.131
|
|
|
|
negative regulation of anterior neural cell fate commitment of the neural plate by wnt signaling pathway
|
GO:0022002 |
1 |
0.131
|
|
|
|
otic vesicle development
|
GO:0071599 |
42 |
0.131
|
|
|
|
positive regulation of cellular process
|
GO:0048522 |
201 |
0.121
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
38 |
0.120
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.120
|
|
|
|
negative regulation of gene expression
|
GO:0010629 |
65 |
0.118
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.112
|
|
|
|
cell migration involved in heart formation
|
GO:0060974 |
10 |
0.111
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
20 |
0.110
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
35 |
0.109
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.107
|
|
|
|
gastrulation
|
GO:0007369 |
208 |
0.106
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.106
|
|
|
|
transmembrane transport
|
GO:0055085 |
120 |
0.104
|
|
|
|
regulation of cellular macromolecule biosynthetic process
|
GO:2000112 |
222 |
0.104
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
23 |
0.102
|
|
|
|
neuron development
|
GO:0048666 |
262 |
0.101
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.100
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.100
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.099
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.099
|
|
|
|
regulation of behavior
|
GO:0050795 |
24 |
0.099
|
|
|
|
otic vesicle morphogenesis
|
GO:0071600 |
34 |
0.098
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
1 |
0.097
|
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.097
|
|
|
|
hemopoiesis
|
GO:0030097 |
183 |
0.097
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.096
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
86 |
0.095
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.094
|
|
|
|
taxis
|
GO:0042330 |
109 |
0.092
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.092
|
|
|
|
regulation of localization
|
GO:0032879 |
104 |
0.091
|
|
|
|
nucleobase containing compound biosynthetic process
|
GO:0034654 |
205 |
0.090
|
|
|
|
regulation of macromolecule biosynthetic process
|
GO:0010556 |
225 |
0.089
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
3 |
0.089
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.088
|
|
|
|
growth
|
GO:0040007 |
174 |
0.088
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.087
|
|
|
|
spinal cord development
|
GO:0021510 |
46 |
0.087
|
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.086
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
18 |
0.085
|
|
|
|
neuron projection guidance
|
GO:0097485 |
86 |
0.085
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
22 |
0.085
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
78 |
0.085
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
43 |
0.085
|
|
|
|
immune system process
|
GO:0002376 |
241 |
0.085
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.085
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
56 |
0.085
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
2 |
0.084
|
|
|
|
behavior
|
GO:0007610 |
74 |
0.082
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
271 |
0.081
|
|
|
|
negative regulation of anterior neural cell fate commitment of the neural plate
|
GO:0022001 |
1 |
0.080
|
|
|
|
cardioblast migration to the midline involved in heart field formation
|
GO:0060975 |
7 |
0.080
|
|
|
|
hepatocyte proliferation
|
GO:0072574 |
2 |
0.080
|
|
|
|
chemotaxis
|
GO:0006935 |
104 |
0.078
|
|
|
|
regulation of rna biosynthetic process
|
GO:2001141 |
213 |
0.078
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
55 |
0.077
|
|
|
|
long chain fatty acid transport
|
GO:0015909 |
1 |
0.075
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
2 |
0.074
|
|
|
|
axonogenesis
|
GO:0007409 |
152 |
0.073
|
|
|
|
metal ion transport
|
GO:0030001 |
58 |
0.072
|
|
|
|
otic placode formation
|
GO:0043049 |
23 |
0.072
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.072
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
79 |
0.071
|
|
|
|
single organism transport
|
GO:0044765 |
206 |
0.071
|
|
|
|
response to alkaloid
|
GO:0043279 |
2 |
0.071
|
|
|
|
neuromast development
|
GO:0048884 |
46 |
0.069
|
|
|
|
sensory system development
|
GO:0048880 |
76 |
0.069
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.067
|
|
|
|
epithelial cell proliferation involved in liver morphogenesis
|
GO:0072575 |
2 |
0.066
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.066
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
1 |
0.066
|
|
|
|
rna biosynthetic process
|
GO:0032774 |
181 |
0.066
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
2 |
0.066
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.065
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
96 |
0.065
|
|
|
|
lateral line development
|
GO:0048882 |
66 |
0.065
|
|
|
|
axon guidance
|
GO:0007411 |
86 |
0.065
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.064
|
|
|
|
cell proliferation
|
GO:0008283 |
80 |
0.063
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.062
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
191 |
0.061
|
|
|
|
cellular localization
|
GO:0051641 |
97 |
0.060
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.059
|
|
|
|
mesoderm development
|
GO:0007498 |
88 |
0.059
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
71 |
0.058
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
59 |
0.057
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
26 |
0.057
|
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.056
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.055
|
|
|
|
pectoral fin development
|
GO:0033339 |
50 |
0.055
|
|
|
|
regulation of transport
|
GO:0051049 |
45 |
0.055
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
59 |
0.054
|
|
|
|
pancreas development
|
GO:0031016 |
84 |
0.054
|
|
|
|
convergent extension involved in organogenesis
|
GO:0060029 |
10 |
0.054
|
|
|
|
negative regulation of cellular biosynthetic process
|
GO:0031327 |
55 |
0.054
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
10 |
0.054
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
18 |
0.053
|
|
|
|
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:1902254 |
5 |
0.053
|
|
|
|
fin morphogenesis
|
GO:0033334 |
53 |
0.053
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
48 |
0.053
|
|
|
|
apoptotic process
|
GO:0006915 |
116 |
0.052
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
29 |
0.052
|
|
|
|
phosphorylation
|
GO:0016310 |
69 |
0.051
|
|
|
|
eye field cell fate commitment involved in camera type eye formation
|
GO:0060898 |
3 |
0.051
|
|
|
|
negative regulation of rna metabolic process
|
GO:0051253 |
48 |
0.050
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.050
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
59 |
0.050
|
|
|
|
regulation of cell development
|
GO:0060284 |
100 |
0.050
|
|
|
|
regeneration
|
GO:0031099 |
91 |
0.050
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.050
|
|
|
|
wnt signaling pathway involved in digestive tract morphogenesis
|
GO:0044333 |
4 |
0.049
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.049
|
|
|
|
gall bladder development
|
GO:0061010 |
1 |
0.049
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
52 |
0.049
|
|
|
|
ear morphogenesis
|
GO:0042471 |
64 |
0.049
|
|
|
|
rhombomere development
|
GO:0021546 |
19 |
0.048
|
|
|
|
cellular protein modification process
|
GO:0006464 |
100 |
0.048
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
27 |
0.048
|
|
|
|
positive regulation of cellular metabolic process
|
GO:0031325 |
94 |
0.047
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
14 |
0.047
|
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.047
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
50 |
0.046
|
|
|
|
cardiogenic plate morphogenesis
|
GO:0003142 |
1 |
0.045
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.045
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
2 |
0.045
|
|
|
|
glial cell differentiation
|
GO:0010001 |
42 |
0.045
|
|
|
|
endocardium formation
|
GO:0060214 |
1 |
0.045
|
|
|
|
heart process
|
GO:0003015 |
71 |
0.044
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
4 |
0.044
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
1 |
0.044
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
3 |
0.044
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.044
|
|
|
|
artery morphogenesis
|
GO:0048844 |
14 |
0.044
|
|
|
|
cation transport
|
GO:0006812 |
81 |
0.044
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.044
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
8 |
0.043
|
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.043
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
1 |
0.043
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
57 |
0.042
|
|
|
|
glucose homeostasis
|
GO:0042593 |
1 |
0.042
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
2 |
0.042
|
|
|
|
regulation of locomotion
|
GO:0040012 |
55 |
0.041
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
15 |
0.041
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.041
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.041
|
|
|
|
multi organism process
|
GO:0051704 |
134 |
0.040
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
161 |
0.040
|
|
|
|
cell cell signaling
|
GO:0007267 |
52 |
0.040
|
|
|
|
posterior lateral line neuromast primordium migration
|
GO:0048920 |
12 |
0.039
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.039
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
22 |
0.039
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
16 |
0.039
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.039
|
|
|
|
developmental cell growth
|
GO:0048588 |
52 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
86 |
0.038
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.037
|
|
|
|
thrombocyte differentiation
|
GO:0002574 |
4 |
0.037
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.036
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
55 |
0.036
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.036
|
|
|
|
programmed cell death
|
GO:0012501 |
119 |
0.036
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.036
|
|
|
|
somite development
|
GO:0061053 |
96 |
0.036
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
35 |
0.036
|
|
|
|
cell fate specification involved in pattern specification
|
GO:0060573 |
3 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
96 |
0.036
|
|
|
|
cell growth
|
GO:0016049 |
57 |
0.036
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.036
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
105 |
0.035
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
179 |
0.035
|
|
|
|
cellular response to stress
|
GO:0033554 |
62 |
0.035
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
48 |
0.035
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.035
|
|
|
|
protein modification process
|
GO:0036211 |
100 |
0.034
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
9 |
0.034
|
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.034
|
|
|
|
axis specification
|
GO:0009798 |
43 |
0.034
|
|
|
|
regulation of mesodermal cell fate specification
|
GO:0042661 |
9 |
0.034
|
|
|
|
spinal cord patterning
|
GO:0021511 |
6 |
0.034
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
1 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
25 |
0.033
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
57 |
0.033
|
|
|
|
midbrain hindbrain boundary development
|
GO:0030917 |
23 |
0.033
|
|
|
|
negative regulation of transcription dna templated
|
GO:0045892 |
45 |
0.033
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.033
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
23 |
0.033
|
|
|
|
organ formation
|
GO:0048645 |
17 |
0.033
|
|
|
|
response to nicotine
|
GO:0035094 |
2 |
0.033
|
|
|
|
kupffer s vesicle development
|
GO:0070121 |
50 |
0.032
|
|
|
|
optic placode formation involved in camera type eye formation
|
GO:0046619 |
3 |
0.032
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
87 |
0.032
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
23 |
0.032
|
|
|
|
aging
|
GO:0007568 |
2 |
0.031
|
|
|
|
morphogenesis of an epithelial sheet
|
GO:0002011 |
49 |
0.031
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
71 |
0.031
|
|
|
|
axon development
|
GO:0061564 |
166 |
0.031
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
246 |
0.031
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
57 |
0.031
|
|
|
|
phosphorus metabolic process
|
GO:0006793 |
109 |
0.031
|
|
|
|
larval development
|
GO:0002164 |
2 |
0.031
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.031
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.031
|
|
|
|
spinal cord motor neuron cell fate specification
|
GO:0021520 |
8 |
0.031
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.030
|
|
|
|
gtp catabolic process
|
GO:0006184 |
2 |
0.030
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
90 |
0.030
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
91 |
0.030
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
51 |
0.030
|
|
|
|
convergent extension
|
GO:0060026 |
118 |
0.030
|
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
3 |
0.030
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
62 |
0.030
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
1 |
0.030
|
|
|
|
gland development
|
GO:0048732 |
143 |
0.030
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.030
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
1 |
0.030
|
|
|
|
regulation of anterior head development
|
GO:2000742 |
2 |
0.029
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
83 |
0.029
|
|
|
|
renal system development
|
GO:0072001 |
94 |
0.029
|
|
|
|
ectodermal placode formation
|
GO:0060788 |
26 |
0.029
|
|
|
|
regulation of bmp signaling pathway involved in heart jogging
|
GO:2000223 |
12 |
0.029
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
28 |
0.028
|
|
|
|
myotube differentiation
|
GO:0014902 |
45 |
0.028
|
|
|
|
atrioventricular valve formation
|
GO:0003190 |
3 |
0.028
|
|
|
|
regulation of synapse organization
|
GO:0050807 |
3 |
0.028
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.028
|
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.028
|
|
|
|
multicellular organism growth
|
GO:0035264 |
4 |
0.027
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
42 |
0.027
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.027
|
|
|
|
positive regulation of metabolic process
|
GO:0009893 |
108 |
0.027
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
65 |
0.027
|
|
|
|
fin development
|
GO:0033333 |
77 |
0.027
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
94 |
0.027
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
9 |
0.027
|
|
|
|
regulation of molecular function
|
GO:0065009 |
70 |
0.026
|
|
|
|
neurological system process
|
GO:0050877 |
62 |
0.026
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
56 |
0.026
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.026
|
|
|
|
regulation of wnt signaling pathway involved in digestive tract morphogenesis
|
GO:2000056 |
2 |
0.026
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.026
|
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.026
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.026
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
4 |
0.025
|
|
|
|
cell cycle arrest
|
GO:0007050 |
1 |
0.025
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
4 |
0.025
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.025
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
129 |
0.025
|
|
|
|
positive regulation of embryonic development
|
GO:0040019 |
3 |
0.025
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
59 |
0.025
|
|
|
|
pigmentation
|
GO:0043473 |
85 |
0.025
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.025
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.024
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
9 |
0.024
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
20 |
0.024
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.024
|
|
|
|
anterior head development
|
GO:0097065 |
2 |
0.024
|
|
|
|
compound eye development
|
GO:0048749 |
2 |
0.024
|
|
|
|
forebrain cell migration
|
GO:0021885 |
1 |
0.024
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
14 |
0.024
|
|
|
|
neuron projection development
|
GO:0031175 |
180 |
0.023
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
4 |
0.023
|
|
|
|
chemical homeostasis
|
GO:0048878 |
49 |
0.023
|
|
|
|
camera type eye morphogenesis
|
GO:0048593 |
108 |
0.023
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.023
|
|
|
|
ectodermal placode morphogenesis
|
GO:0071697 |
32 |
0.023
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
26 |
0.023
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
55 |
0.023
|
|
|
|
thalamus development
|
GO:0021794 |
6 |
0.023
|
|
|
|
cranial nerve development
|
GO:0021545 |
42 |
0.023
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
23 |
0.023
|
|
|
|
peptide transport
|
GO:0015833 |
1 |
0.022
|
|
|
|
endocardium morphogenesis
|
GO:0003160 |
4 |
0.022
|
|
|
|
regulation of axonogenesis
|
GO:0050770 |
32 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
92 |
0.022
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
4 |
0.022
|
|
|
|
response to lipid
|
GO:0033993 |
60 |
0.022
|
|
|
|
regulation of multicellular organism growth
|
GO:0040014 |
4 |
0.022
|
|
|
|
optic placode formation
|
GO:0001743 |
4 |
0.022
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
68 |
0.021
|
|
|
|
regulation of axon extension
|
GO:0030516 |
24 |
0.021
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
69 |
0.021
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
133 |
0.021
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
12 |
0.021
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
2 |
0.021
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
1 |
0.021
|
|
|
|
artery development
|
GO:0060840 |
22 |
0.021
|
|
|
|
endocardial progenitor cell migration to the midline involved in heart field formation
|
GO:0003262 |
4 |
0.021
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
20 |
0.021
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901213 |
15 |
0.021
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.021
|
|
|
|
response to drug
|
GO:0042493 |
3 |
0.021
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
35 |
0.021
|
|
|
|
floor plate development
|
GO:0033504 |
15 |
0.021
|
|
|
|
foregut morphogenesis
|
GO:0007440 |
4 |
0.020
|
|
|
|
death
|
GO:0016265 |
121 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
3 |
0.020
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
2 |
0.020
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
4 |
0.020
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
96 |
0.020
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
44 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
46 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.020
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
146 |
0.020
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
29 |
0.020
|
|
|
|
embryonic neurocranium morphogenesis
|
GO:0048702 |
15 |
0.020
|
|
|
|
trigeminal motor nucleus development
|
GO:0021731 |
2 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
12 |
0.020
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.019
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
11 |
0.019
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
21 |
0.019
|
|
|
|
post embryonic morphogenesis
|
GO:0009886 |
4 |
0.019
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
3 |
0.019
|
|
|
|
pectoral fin morphogenesis
|
GO:0035138 |
29 |
0.019
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
2 |
0.019
|
|
|
|
system process
|
GO:0003008 |
185 |
0.019
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.019
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
30 |
0.019
|
|
|
|
neural tube patterning
|
GO:0021532 |
33 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.019
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
9 |
0.019
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
20 |
0.019
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
37 |
0.019
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.019
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
3 |
0.019
|
|
|
|
ion transport
|
GO:0006811 |
114 |
0.018
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.018
|
|
|
|
anterior commissure morphogenesis
|
GO:0021960 |
3 |
0.018
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
2 |
0.018
|
|
|
|
circadian sleep wake cycle process
|
GO:0022410 |
2 |
0.018
|
|
|
|
phosphate containing compound metabolic process
|
GO:0006796 |
108 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
34 |
0.018
|
|
|
|
camp metabolic process
|
GO:0046058 |
11 |
0.018
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
38 |
0.018
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
12 |
0.018
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
8 |
0.018
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
68 |
0.018
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
2 |
0.018
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
22 |
0.018
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
4 |
0.017
|
|
|
|
hepatic duct development
|
GO:0061011 |
2 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
2 |
0.017
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
27 |
0.017
|
|
|
|
epithelium regeneration
|
GO:1990399 |
14 |
0.017
|
|
|
|
photoreceptor cell fate commitment
|
GO:0046552 |
1 |
0.017
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
55 |
0.017
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
1 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
29 |
0.017
|
|
|
|
cartilage morphogenesis
|
GO:0060536 |
13 |
0.017
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
19 |
0.017
|
|
|
|
protein phosphorylation
|
GO:0006468 |
47 |
0.017
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
18 |
0.017
|
|
|
|
opioid receptor signaling pathway
|
GO:0038003 |
3 |
0.017
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
97 |
0.017
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
43 |
0.016
|
|
|
|
positive regulation of biological process
|
GO:0048518 |
253 |
0.016
|
|
|
|
regulation of mononuclear cell migration
|
GO:0071675 |
1 |
0.016
|
|
|
|
ectodermal placode development
|
GO:0071696 |
37 |
0.016
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
65 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
4 |
0.016
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.016
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
3 |
0.016
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
3 |
0.016
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
3 |
0.016
|
|
|
|
otolith development
|
GO:0048840 |
32 |
0.016
|
|
|
|
catechol containing compound biosynthetic process
|
GO:0009713 |
2 |
0.016
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
244 |
0.016
|
|
|
|
response to hormone
|
GO:0009725 |
48 |
0.016
|
|
|
|
skin development
|
GO:0043588 |
54 |
0.016
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.016
|
|
|
|
negative regulation of blood circulation
|
GO:1903523 |
2 |
0.016
|
|
|
|
otic vesicle formation
|
GO:0030916 |
27 |
0.016
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
17 |
0.016
|
|
|
|
negative regulation of nucleotide biosynthetic process
|
GO:0030809 |
7 |
0.016
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
1 |
0.016
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
10 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
29 |
0.015
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
1 |
0.015
|
|
|
|
regulation of ion transport
|
GO:0043269 |
22 |
0.015
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.015
|
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.015
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
1 |
0.015
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
17 |
0.015
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.015
|
|
|
|
regulation of cell fate specification
|
GO:0042659 |
20 |
0.015
|
|
|
|
neuron projection extension
|
GO:1990138 |
45 |
0.015
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
3 |
0.015
|
|
